Changing to Avastin could save NHS £100m a year - Cameron Optometry | Cameron Optometry
Changing to Avastin could save NHS £100m a year

Changing to Avastin could save NHS £100m a year

Posted on 25th November 2014

The drug Avastin has been in the newscalling for its use in the UK in a bid to save millions each year.

eye-care

Popular in the US, Avastin is used for patients with age-related macular degeneration (AMD). It has been on the market for years, gone through all the testing and has been proven to be as effective as Lucentis, the NHS approved drug for the same condition. The difference is cost. Lucentis typically costs around £700 per treatment, compared to Avastin which is about £70. Yet red tape seems to be halting its use.

It is currently unlicensed in the UK so should anything go wrong with its use, the practitioner may not be legally covered. However, in times of austerity and it is perhaps time for the NHS to move forward and license its use.


Related Posts

Is homeschooling having a negative effect on your child’s vision?

28th January 2021

We’ve had several patients get in touch to say their children are complaining of sore eyes and headaches at the moment. Older children in particular, are spending many hours on screens whilst homesc...

Read more

Murray McGrath

18th January 2021

We are saddened to inform you that at the end of last year we lost our founding partner, Murray McGrath, who many of you will have been treated by over the years. Cameron Optometry started out as W M ...

Read more

COVID-19 advice

07th January 2021

This page will have our latest information on the care we can provide during the COVID-19 pandemic. You can also find information on our Facebook page. LATEST UPDATE Thursday, 7 January, 2021 We are...

Read more

Welcome to our new optometrist

16th December 2020

We are delighted to let you know that we have a new optometrist joining the practice in January. Alexandra Young is incredibly highly regarded and we are excited to welcome her to the team. In addi...

Read more